Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Adv Healthc Mater ; 5(2): 244-54, 2016 Jan 21.
Artículo en Inglés | MEDLINE | ID: mdl-26619161

RESUMEN

Stable and low-cost multiplexed drug sensitivity assays using small volumes of cells or tissue are in demand for personalized medicine, including patient-specific combination chemotherapy. Spatially defined projected light photopolymerization of hydrogels with embedded active compounds is introduced as a flexible and cost-efficient method for producing multiplexed dosing assays. The high spatial resolution of light projector technology defines multiple compound doses by the volume of individual compound-embedded hydrogel segments. Quantitative dosing of multiple proteins with a dynamic range of 1-2 orders of magnitude is demonstrated using fluorescently labeled albumins. The hydrogel matrix results from photopolymerization of low-cost poly(ethylene glycol) diacrylates (PEGDA), and tuning of the PEGDA composition enables fast complete dosing of all tested species. Dosing of hydrophilic and hydrophobic compounds is demonstrated using two first-line chemotherapy regimens combining oxaliplatin, SN-38, 5-fluorouracil, and folinic acid, with each compound being dosed from a separate light-defined hydrogel segment. Cytotoxicity studies using a colorectal cancer cell line show equivalent effects of dissolved and released compounds. Further control of the dosing process is demonstrated by liposomal encapsulation of oxaliplatin, stable embedding of the liposomes in hydrogels for more than 3 months, and heat-triggered complete release of the loaded oxaliplatin.


Asunto(s)
Bioensayo/métodos , Hidrogel de Polietilenoglicol-Dimetacrilato/química , Antineoplásicos/farmacología , Muerte Celular/efectos de los fármacos , Línea Celular Tumoral , Relación Dosis-Respuesta a Droga , Liberación de Fármacos , Estabilidad de Medicamentos , Fluorouracilo/farmacología , Humanos , Leucovorina/farmacología , Liposomas/química , Compuestos Organoplatinos/farmacología , Oxaliplatino , Polietilenglicoles/química , Temperatura , Factores de Tiempo
2.
Biomacromolecules ; 15(3): 894-9, 2014 Mar 10.
Artículo en Inglés | MEDLINE | ID: mdl-24524417

RESUMEN

Immobilization of proteins onto polymer surfaces usually requires specific reactive functional groups. Here, we show an easy one-step method to conjugate protein covalently onto almost any polymer surface, including low protein-binding poly(ethylene glycol) (PEG), without the requirement for the presence of specific functional groups. Several types of proteins, including alkaline phosphatase, bovine serum albumin, and polyclonal antibodies, were photoimmobilized onto a PEG-coated polymer surface using a water-soluble benzophenone as photosensitizer. Protein functionality after immobilization was verified for both enzymes and antibodies, and their presence on the surface was confirmed by X-ray photoelectron spectroscopy (XPS) and confocal fluorescence microscopy. Conjugation of capture antibody onto the PEG coating was employed for a simplified ELISA protocol without the need for blocking uncoated surface areas, showing ng/mL sensitivity to a cytokine antigen target. Moreover, spatially patterned attachment of fluorescently labeled protein onto the low-binding PEG-coated surface was achieved with a projection lithography system that enabled the creation of micrometer-sized protein features.


Asunto(s)
Proteínas Inmovilizadas/química , Polietilenglicoles/química , Polímeros/química , Albúmina Sérica Bovina/química , Fosfatasa Alcalina/química , Animales , Anticuerpos/química , Bovinos , Espectroscopía de Fotoelectrones , Propiedades de Superficie
3.
Biomicrofluidics ; 8(6): 064127, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-25587375

RESUMEN

Definable surface chemistry is essential for many applications of microfluidic polymer systems. However, small cross-section channels with a high surface to volume ratio enhance passive adsorption of molecules that depletes active molecules in solution and contaminates the channel surface. Here, we present a one-step photochemical process to coat the inner surfaces of closed microfluidic channels with a nanometer thick layer of poly(ethylene glycol) (PEG), well known to strongly reduce non-specific adsorption, using only commercially available reagents in an aqueous environment. The coating consists of PEG diacrylate (PEGDA) covalently grafted to polymer surfaces via UV light activation of the water soluble photoinitiator benzoyl benzylamine, a benzophenone derivative. The PEGDA coating was shown to efficiently limit the adsorption of antibodies and other proteins to <5% of the adsorbed amount on uncoated polymer surfaces. The coating could also efficiently suppress the adhesion of mammalian cells as demonstrated using the HT-29 cancer cell line. In a subsequent equivalent process step, protein in aqueous solution could be anchored onto the PEGDA coating in spatially defined patterns with a resolution of <15 µm using an inverted microscope as a projection lithography system. Surface patterns of the cell binding protein fibronectin were photochemically defined inside a closed microfluidic device that was initially homogeneously coated by PEGDA. The resulting fibronectin patterns were shown to greatly improve cell adhesion compared to unexposed areas. This method opens for easy surface modification of closed microfluidic systems through combining a low protein binding PEG-based coating with spatially defined protein patterns of interest.

4.
Nanoscale ; 5(17): 8192-201, 2013 Sep 07.
Artículo en Inglés | MEDLINE | ID: mdl-23835641

RESUMEN

Ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles are currently being used as a magnetic resonance imaging (MRI) contrast agent in vivo, mainly by their passive accumulation in tissues of interest. However, a higher specificity can ideally be achieved when the nanoparticles are targeted towards cell specific receptors and this may also facilitate specific drug delivery by an enhanced target-mediated endocytosis. We report efficient peptide-mediated targeting of magnetic nanoparticles to cells expressing the urokinase plasminogen activator receptor (uPAR), a surface biomarker for poor patient prognosis shared by several cancers including breast, colorectal, and gastric cancers. Conjugation of a uPAR specific targeting peptide onto polyethylene glycol (PEG) coated USPIO nanoparticles by click chemistry resulted in a five times higher uptake in vitro in a uPAR positive cell line compared to nanoparticles carrying a non-binding control peptide. In accordance with specific receptor-mediated recognition, a low uptake was observed in the presence of an excess of ATF, a natural ligand for uPAR. The uPAR specific magnetic nanoparticles can potentially provide a useful supplement for tumor patient management when combined with MRI and drug delivery.


Asunto(s)
Nanopartículas de Magnetita/química , Péptidos/metabolismo , Receptores del Activador de Plasminógeno Tipo Uroquinasa/metabolismo , Secuencia de Aminoácidos , Química Clic , Compuestos Férricos/química , Colorantes Fluorescentes/química , Células HEK293 , Humanos , Microscopía Confocal , Péptidos/síntesis química , Péptidos/química , Polietilenglicoles , Unión Proteica , Receptores del Activador de Plasminógeno Tipo Uroquinasa/antagonistas & inhibidores , Receptores del Activador de Plasminógeno Tipo Uroquinasa/genética
5.
Lab Chip ; 13(4): 669-75, 2013 Feb 21.
Artículo en Inglés | MEDLINE | ID: mdl-23254780

RESUMEN

The non-specific adsorption of dissolved analytes strongly reduces the sensitivity and reliability in polymer microanalytical systems. Here, a one-step aqueous phase procedure modifies polymer material surfaces to strongly reduce their non-specific adsorption of a broad range of organic analytes including hydrophobic and hydrophilic drugs (0.23 < ClogP < 8.95), small and large proteins (insulin, albumin, IgG), and DNA. The coating is shown to limit the adsorption of even highly hydrophobic drugs (ClogP > 8) in their pharmaceutically relevant concentration range ≤100 nM. The low adsorption is mediated by photochemical conjugation, where polyethylene glycol (PEG) polymers in aqueous solution are covalently bound to the surface by UV illumination of dissolved benzophenone and a functionalized PEG. The method can coat the interior of polymer systems made from a range of materials commonly used in microanalytical systems, including polystyrene (PS), cyclic olefin copolymer (COC), liquid crystalline polymer (LCP), and polyimide (PI).


Asunto(s)
ADN/química , Inmunoglobulina G/química , Insulina/química , Preparaciones Farmacéuticas/química , Polímeros/química , Albúmina Sérica Bovina/química , Adsorción , Cromatografía Líquida de Alta Presión , Espectrometría de Masas , Estructura Molecular , Espectrofotometría , Propiedades de Superficie , Rayos X
6.
Nanoscale ; 4(7): 2352-61, 2012 Apr 07.
Artículo en Inglés | MEDLINE | ID: mdl-22395568

RESUMEN

Iron oxide nanoparticles have found widespread applications in different areas including cell separation, drug delivery and as contrast agents. Due to water insolubility and stability issues, nanoparticles utilized for biological applications require coatings such as the commonly employed polyethylene glycol (PEG). Despite its frequent use, the influence of PEG coatings on the physicochemical and biological properties of iron nanoparticles has hitherto not been studied in detail. To address this, we studied the effect of 333-20,000 Da PEG coatings that resulted in larger hydrodynamic size, lower surface charge, longer circulation half-life, and lower uptake in macrophage cells when the particles were coated with high molecular weight (M(w)) PEG molecules. By use of magnetic resonance imaging, we show coating-dependent in vivo uptake in murine tumors with an optimal coating M(w) of 10,000 Da.


Asunto(s)
Materiales Biocompatibles Revestidos/farmacocinética , Compuestos Férricos/farmacocinética , Neoplasias/metabolismo , Polietilenglicoles/farmacocinética , Animales , Línea Celular Tumoral , Materiales Biocompatibles Revestidos/química , Medios de Contraste/química , Medios de Contraste/farmacocinética , Sistemas de Liberación de Medicamentos , Compuestos Férricos/química , Magnetismo , Nanopartículas del Metal/química , Ratones , Ratones Endogámicos C3H , Modelos Biológicos , Peso Molecular , Neoplasias/diagnóstico , Neoplasias/patología , Ácido Oléico/química , Ácido Oléico/farmacocinética , Tamaño de la Partícula , Polietilenglicoles/química , Silanos/química , Silanos/farmacocinética , Distribución Tisular
7.
J Immunol ; 184(4): 1931-45, 2010 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-20053940

RESUMEN

The binding of Abs to microbial surfaces followed by complement activation constitutes an important line of defense against infections. In this study, we have investigated the relationship between complement activation and the binding of human IgM Abs to surfaces with different curvatures. IgM Abs to dextran were shown to activate complement potently on dextran-coated particles having a diameter around 250 nm, whereas larger (600 nm) particles were less potent activators. This selectivity regarding particle dimension was also found for complement activation by colloidal substances of microbial origin. Peptidoglycan (PGN) is the major chemical component in the cell wall of Gram-positive bacteria. Fragments of purified PGN with sizes of approximately 100 nm promoted complement activation effectively through the classical pathway. By contrast, larger or smaller fragments of PGN did not activate complement strongly. A careful analysis of PGN fragments released during planctonic growth of Staphylococcus aureus showed that these include curvatures that would permit strong IgM-mediated complement activation, whereas the curvature of intact cells would be less effective for such activation. Consistently, we found that the suspended PGN fragments were strong activators of complement through the classical pathway. We suggest that these fragments act as decoy targets for complement activation, providing protection for S. aureus against the host immune response to infection.


Asunto(s)
Vía Clásica del Complemento/inmunología , Staphylococcus aureus/inmunología , Antígenos Bacterianos/química , Antígenos Bacterianos/inmunología , Sitios de Unión de Anticuerpos , Complemento C3/metabolismo , Dextranos/inmunología , Dextranos/metabolismo , Dextranos/ultraestructura , Compuestos Férricos/química , Compuestos Férricos/metabolismo , Humanos , Inmunoglobulina G/metabolismo , Inmunoglobulina M/metabolismo , Microscopía de Fuerza Atómica , Nanopartículas/química , Tamaño de la Partícula , Peptidoglicano/inmunología , Peptidoglicano/metabolismo , Peptidoglicano/ultraestructura , Unión Proteica/inmunología , Staphylococcus aureus/crecimiento & desarrollo , Staphylococcus aureus/ultraestructura , Propiedades de Superficie
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA